lilly glp-1 drugs Eli stock soars on encouraging results for daily weight-loss pill Lilly's Double-Beat Widens the GLP-1

This guide examines peer-reviewed research on EVOO and GLP-1 secretion, hydroxytyrosol and insulin sensitivity, oleocanthal and inflammation, and why these olive-specific compounds are distinct from other dietary polyphenols

Understanding these interactions requires individualized provider guidance based on your complete medical history and current medication list

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

Consume Protein-Rich Foods Protein promotes GLP-1 secretion, aiding satiety and blood sugar control

This case highlights the need for gradual insulin tapering and close monitoring while transitioning from insulin therapy to GIP/GLP-1 receptor agonists.

Regulatory submission for retatrutide is expected in 2026